Book Review - Richard Goldberg, Medicinal Product Liability and Regulation (Hart Publishing, Oxford, 2013) 214pp
Abstract
In December 2013, settlement was reached between approximately 100 Australian and New Zealand Thalidomide victims and the company which had acted as the Australian distributor of the infamous drug, thus putting to rest the possibility of litigation. Around the same time, Thalidomide victims in the United Kingdom (UK) launched a similar bid for compensation against the manufacturer and distributor. It is clear that despite a lengthy amount of time having passed ever since the thalidomide disaster commenced in 1962, the controversy over compensation continues. Indeed, the author of Medicinal Product Liability and Regulation (published before the announcement of the British legal claim), Professor Goldberg, notes that claims for resulting birth defects continue to emerge right into the present day. His prescient insight into the contemporary relevance of compensation for pharmaceutical injuries thus makes Medicinal Product Liability and Regulation a very relevant addition to the small body of scholarship that is available on this rather specific and complex issue.
Published
Dec 17, 2014
How to Cite
TSUI, Mabel.
Book Review - Richard Goldberg, Medicinal Product Liability and Regulation (Hart Publishing, Oxford, 2013) 214pp.
QUT Law Review, [S.l.], v. 14, n. 2, dec. 2014.
ISSN 2201-7275.
Available at: <https://lr.law.qut.edu.au/article/view/628>. Date accessed: 01 feb. 2021.
doi: https://doi.org/10.5204/qutlr.v14i2.628.
Section
Book Reviews
Keywords
Thalidomide; Medicinal Product Liability ; pharmaceutical regulation
Since 2015-12-04
Abstract Views
1771
PDF Views
1594
Until 2015-12-04:
Abstract Views
503
PDF Views
736
Authors who publish with this journal retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Articles in this journal are published under the Creative Commons Attribution Licence (CC-BY). This is to achieve more legal certainty about what readers can do with published articles, and thus a wider dissemination and archiving, which in turn makes publishing with this journal more valuable for authors.